您的购物车当前为空
SR12418是一种特异性的REV-ERB合成配体,能够在TR-FRET实验中和REV-ERBα(IC50=68 nM)和REV-ERBβ(IC50=119 nM)结合。SR12418能够在EL4细胞中抑制IL-17A表达,抑制TH17细胞的分化,可用于研究实验性自身免疫性脑脊髓炎(EAE)和结肠炎。


为众多的药物研发团队赋能,
让新药发现更简单!
SR12418是一种特异性的REV-ERB合成配体,能够在TR-FRET实验中和REV-ERBα(IC50=68 nM)和REV-ERBβ(IC50=119 nM)结合。SR12418能够在EL4细胞中抑制IL-17A表达,抑制TH17细胞的分化,可用于研究实验性自身免疫性脑脊髓炎(EAE)和结肠炎。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 639 | In Stock | |
| 5 mg | ¥ 1,950 | In Stock | |
| 10 mg | ¥ 3,450 | In Stock | |
| 25 mg | ¥ 6,790 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,290 | In Stock |
SR12418 相关产品
| 产品描述 | SR12418 is a specific synthetic ligand for REV-ERB, demonstrating binding affinity for both REV-ERBα (IC50 = 68 nM) and REV-ERBβ (IC50 = 119 nM) in TR-FRET assays. SR12418 inhibits IL-17A expression in EL4 cells and suppresses TH17 cell differentiation, making it suitable for studies on experimental autoimmune encephalomyelitis (EAE) and colitis. |
| 体外活性 | SR12418 以 5 μM 的浓度作用 96 小时,可抑制 TH17 细胞的生长 [1]。 |
| 体内活性 | SR12418(50 mg/kg、腹腔注射、每日两次)可抑制实验性自身免疫性脑脊髓炎(EAE)的发病进程及疾病严重程度[1]。 |
| 分子量 | 483.57 |
| 分子式 | C31H30FNO3 |
| CAS No. | 1801185-08-9 |
| Smiles | C(=O)(N1[C@H](COC2=CC=C(OC(C)(C)C)C=C2)CC=3C(C1)=CC=C(F)C3)C=4C5=C(C=CC4)C=CC=C5 |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (165.44 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容